## Abstract ## Background Homeostasis of circulating T cells is regulated in complex ways that have not yet been well defined. The balance between type 1 and type 2 Tβcell subsets in cancer patients is thought to modulate antitumor immunity. Meanwhile, CD4+CD25+ regulatory T cells (Treg), which ar
Clinical significance of regulatory T cells and CD8+ effector populations in patients with human endometrial carcinoma
β Scribed by Wen-Chun Chang; Chao-Hsu Li; Su-Cheng Huang; Daw-Yuan Chang; Li-Yun Chou; Bor-Ching Sheu
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 741 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract To evaluate the expressions of CD4^+^CD25^high^CD127^low/β^ regulatory T cells (Tregs) in peripheral blood from patients with transitional cell carcinoma (TCC) in urinary system, we investigated the proportion of Treg population in CD4^+^ T from 93 patients with TCC, 38 with benign urin
## Abstract ## Background. Patients with head and neck squamous cell carcinoma (HNSCC) commonly have an imbalance in T helper (Th)1/Th2βtype cytokines and elevated levels of CD4^+^CD25^high^ regulatory T cells (Treg). Here, we investigated the association of circulating interleukin (IL)10, IL12, a
## Abstract CD4^+^CD25^hi^CTLA4^+^FoxP3^+^ regulatory T cells (Treg) have been shown to maintain immune tolerance against self antigens and increased circulating frequencies have been reported in various types of cancers. Circulating invariant natural killer Tβcells (iNKT) are reduced in cancer pat
In primary biliary cirrhosis (PBC), patients develop a multilineage response to a highly restricted peptide of the E2 component of pyruvate dehydrogenase (PDC-E2) involving autoantibody and autoreactive cluster of differentiation (CD)4 1 and CD8 1 T-cell responses. Recent data from murine models hav